Literature DB >> 12065879

Distribution of multiple sclerosis in Sweden based on mortality and disability compensation statistics.

Anne-Marie Landtblom1, Trond Riise, Alexei Boiko, Birgitta Söderfeldt.   

Abstract

Previous studies have shown the Fennoscandian region to be a high-risk area for multiple sclerosis (MS). In order to investigate the distribution of MS in Sweden, mortality (1952-1992) and disability pensioning statistics (1971-1994) were studied. A total of 11,414 cases with a disability pension and 5,421 cases with MS on their death certificate were analysed according to county and time period and the results were compared with the mortality figures for amyotrophic lateral sclerosis (ALS) and disability pensioning statistics for Parkinson's disease. We found increasing rates of both MS mortality and disability pensioning. Disability pensioning correlated well with mortality 10 years later (r = 0.42, p = 0.04). We also found a marked geographical variation. Värmland county had the highest mortality, with 14 out of its 16 municipalities having higher rates than the national mean. Unexpectedly, we found a high correlation between mortality due to MS and ALS (r = 0.60, p = 0.002). Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12065879     DOI: 10.1159/000059518

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  4 in total

1.  Multiple sclerosis is primarily a neurodegenerative disease.

Authors:  Abhijit Chaudhuri
Journal:  J Neural Transm (Vienna)       Date:  2013-08-28       Impact factor: 3.575

2.  Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study.

Authors:  Eleonora Tavazzi; Maria Marcella Laganà; Niels Bergsland; Paola Tortorella; Giovanna Pinardi; Christian Lunetta; Massimo Corbo; Marco Rovaris
Journal:  Neurol Sci       Date:  2014-09-17       Impact factor: 3.307

3.  No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.

Authors:  An Goris; Jessica van Setten; Frank Diekstra; Stephan Ripke; Nikolaos A Patsopoulos; Stephen J Sawcer; Michael van Es; Peter M Andersen; Judith Melki; Vincent Meininger; Orla Hardiman; John E Landers; Robert H Brown; Aleksey Shatunov; Nigel Leigh; Ammar Al-Chalabi; Christopher E Shaw; Bryan J Traynor; Adriano Chiò; Gabriella Restagno; Gabriele Mora; Roel A Ophoff; Jorge R Oksenberg; Philip Van Damme; Alastair Compston; Wim Robberecht; Bénédicte Dubois; Leonard H van den Berg; Philip L De Jager; Jan H Veldink; Paul I W de Bakker
Journal:  Hum Mol Genet       Date:  2013-11-13       Impact factor: 6.150

Review 4.  Risk factors for amyotrophic lateral sclerosis.

Authors:  Caroline Ingre; Per M Roos; Fredrik Piehl; Freya Kamel; Fang Fang
Journal:  Clin Epidemiol       Date:  2015-02-12       Impact factor: 4.790

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.